BECLOMETHASONE DIPROPIONATE AEROSOL TREATMENT OF HAY FEVER
- 1 November 1975
- Vol. 30 (5) , 316-325
- https://doi.org/10.1111/j.1398-9995.1975.tb00208.x
Abstract
In a controlled, double‐blind study 20 children and adults, suffering from summer hay fever, were treated intranasally with a daily dose of 200 μg, 300 μg or 400 μg beclomethasone dipropionate (Beconase®, Becotide Nasal®) or with placebo for 2 weeks during the hay fever season. No beneficial effect of the placebo treatment was observed. In patients treated with 200 μg and 300 μg beclomethasone dipropionate a day there was a moderate decrease in nasal symptom scores and in use of antihistamine tablets. As the results indicated 400 μg a day to have the most pronounced effect on nasal symptoms, this dosage is recommended for children as well as adults suffering from summer hay fever.Keywords
This publication has 10 references indexed in Scilit:
- Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosolClinical and Experimental Allergy, 1975
- Double-blind Cross-over Trial Comparing Intranasal Beclomethasone Dipropionate and Placebo in Perennial RhinitisBMJ, 1974
- The effect of intra‐nasal beclomethasone dipropionate on adrenal functionClinical and Experimental Allergy, 1974
- LOCAL EFFECT OF INTRANASAL BECLOMETHASONE DIPROPIONATE AEROSOL IN PERENNIAL RHINITISAllergy, 1974
- Local Effect of Intranasal Beclomethasone Dipropionate Aerosol in Hay FeverBMJ, 1973
- The effect of oral and inhaled beclomethasone dipropionate on adrenal functionClinical and Experimental Allergy, 1973
- Beclomethasone aerosol in childhood asthmaArchives of Disease in Childhood, 1973
- BECLOMETHASONE DIPROPIONATE AEROSOL EFFECT ON THE ADRENALS IN NORMAL PERSONSAllergy, 1973
- EFFECT OF BECLOMETHASONE DIPROPIONATE DELIVERED BY AEROSOL IN PATIENTS WITH ASTHMAThe Lancet, 1972
- Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic AsthmaBMJ, 1972